56
Participants
Start Date
May 17, 2016
Primary Completion Date
July 29, 2016
Study Completion Date
August 3, 2016
Empagliflozin
Linagliptin
Humanpharmakologisches Zentrum Biberach, Biberach
Lead Sponsor
Eli Lilly and Company
INDUSTRY
Boehringer Ingelheim
INDUSTRY